DE60111811D1 - Verwendung von thiamphenicol in der behandlung von infektionen verursacht durch chlamydia pneumoniae - Google Patents

Verwendung von thiamphenicol in der behandlung von infektionen verursacht durch chlamydia pneumoniae

Info

Publication number
DE60111811D1
DE60111811D1 DE60111811T DE60111811T DE60111811D1 DE 60111811 D1 DE60111811 D1 DE 60111811D1 DE 60111811 T DE60111811 T DE 60111811T DE 60111811 T DE60111811 T DE 60111811T DE 60111811 D1 DE60111811 D1 DE 60111811D1
Authority
DE
Germany
Prior art keywords
thiamphenicol
treatment
chlamydia pneumoniae
infections caused
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111811T
Other languages
English (en)
Other versions
DE60111811T2 (de
Inventor
Giovanni Colombo
Domenico Ungheri
Luciano Licciardello
Maria Gismondo
Lorenzo Drago
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of DE60111811D1 publication Critical patent/DE60111811D1/de
Application granted granted Critical
Publication of DE60111811T2 publication Critical patent/DE60111811T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
DE60111811T 2000-04-11 2001-04-02 Verwendung von thiamphenicol in der behandlung von infektionen verursacht durch chlamydia pneumoniae Expired - Lifetime DE60111811T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI000776 2000-04-11
IT2000MI000776A IT1318459B1 (it) 2000-04-11 2000-04-11 Uso del tiamfenicolo e di suoi derivati per la preparazione dicomposizioni farmaceutiche utili per il trattamento di infezioni da
PCT/EP2001/003709 WO2001076585A2 (en) 2000-04-11 2001-04-02 Use of thiamphenicol for the treatment of chlamydia pneumoniae infections

Publications (2)

Publication Number Publication Date
DE60111811D1 true DE60111811D1 (de) 2005-08-11
DE60111811T2 DE60111811T2 (de) 2006-04-20

Family

ID=11444807

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111811T Expired - Lifetime DE60111811T2 (de) 2000-04-11 2001-04-02 Verwendung von thiamphenicol in der behandlung von infektionen verursacht durch chlamydia pneumoniae

Country Status (10)

Country Link
US (1) US6833389B2 (de)
EP (1) EP1212049B1 (de)
JP (1) JP4796258B2 (de)
AT (1) ATE299020T1 (de)
DE (1) DE60111811T2 (de)
DK (1) DK1212049T3 (de)
ES (1) ES2245367T3 (de)
IT (1) IT1318459B1 (de)
PT (1) PT1212049E (de)
WO (1) WO2001076585A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021405A1 (it) * 2002-06-25 2003-12-29 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato respiratorio
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA703436B (en) * 1969-06-07 1971-01-27 Zambon Spa A process for the preparation of thiamphenicol glycinate acetylcysteinate
DE3543021A1 (de) * 1985-12-05 1987-06-11 Boehringer Mannheim Gmbh Verbesserte verfahren zur herstellung von d-threo-1-(p-methylsulfonylphenyl) -2-dichloracetamido-propandiol-1,3-(thiamphenicol) sowie verwendung geeigneter zwischenprodukte
JPS6379822A (ja) * 1986-09-24 1988-04-09 Fujita Seiyaku Kk 動物用チアンフエニコ−ル注射用組成物及びその注射用溶液
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
IT1317836B1 (it) * 2000-02-16 2003-07-15 Zambon Spa Uso del tiamfenicolo per la preparazione di composizioni farmaceuticheutili per il trattamento di infezioni da staphylococci

Also Published As

Publication number Publication date
DK1212049T3 (da) 2005-10-24
PT1212049E (pt) 2005-11-30
WO2001076585A3 (en) 2002-03-28
WO2001076585A2 (en) 2001-10-18
IT1318459B1 (it) 2003-08-25
ITMI20000776A1 (it) 2001-10-11
US20030100614A1 (en) 2003-05-29
JP4796258B2 (ja) 2011-10-19
JP2003530347A (ja) 2003-10-14
EP1212049A2 (de) 2002-06-12
ES2245367T3 (es) 2006-01-01
ITMI20000776A0 (it) 2000-04-11
US6833389B2 (en) 2004-12-21
ATE299020T1 (de) 2005-07-15
DE60111811T2 (de) 2006-04-20
EP1212049B1 (de) 2005-07-06

Similar Documents

Publication Publication Date Title
PT1347971E (pt) Inibidores tiazolilicos de tirosina-cinases da familia tec
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
DK1392282T3 (da) Dermatologiske og kosmetiske sammensætninger, der omfatter et furfurylderivat
PT1263724E (pt) Novos compostos
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20005265D0 (no) Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
EA200201214A1 (ru) Замещенные тиоацетамиды
NO20030411L (no) Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
BR9909248A (pt) Inibidores de enzima
NO20052494D0 (no) Preparater inneholdende melatonin, gingko biloba og biotin.
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
BR0205812A (pt) Benzimidazois úteis no tratamento da disfunção sexual
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
SE0003476D0 (sv) Compounds
ATE324112T1 (de) Topische behandlung bei der mastalgie
NO20010940D0 (no) TAN-1057 derivater
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
BR9708297A (pt) Compostos composição farmacéutica cosmposição e uso de uma composição cosmética
DE60111811D1 (de) Verwendung von thiamphenicol in der behandlung von infektionen verursacht durch chlamydia pneumoniae
BR0011261B1 (pt) composiÇço oral compreendendo perlita, e, uso de perlita.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ZAMBON S.P.A., BRESSO, IT